X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (54818) 54818
Book Review (4829) 4829
Publication (3125) 3125
Newsletter (254) 254
Book Chapter (139) 139
Magazine Article (54) 54
Conference Proceeding (42) 42
Dissertation (40) 40
Newspaper Article (16) 16
Book / eBook (13) 13
Reference (4) 4
Web Resource (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (48732) 48732
humans (47410) 47410
male (28884) 28884
female (28747) 28747
middle aged (25541) 25541
aged (22540) 22540
oncology (17775) 17775
adenocarcinoma (17229) 17229
adenocarcinoma - secondary (16582) 16582
cancer (15746) 15746
adult (14997) 14997
adenocarcinoma - pathology (14154) 14154
surgery (9238) 9238
metastasis (8991) 8991
prognosis (8984) 8984
carcinoma (8892) 8892
aged, 80 and over (8355) 8355
adenocarcinoma - surgery (7642) 7642
neoplasm staging (7088) 7088
tumors (7023) 7023
adenocarcinoma - drug therapy (6492) 6492
animals (6425) 6425
chemotherapy (6280) 6280
abridged index medicus (6273) 6273
immunohistochemistry (5885) 5885
lung neoplasms - pathology (5789) 5789
pathology (5663) 5663
retrospective studies (5605) 5605
lymphatic metastasis (5439) 5439
expression (5328) 5328
treatment outcome (5321) 5321
analysis (5030) 5030
adenocarcinoma - metabolism (4969) 4969
survival (4929) 4929
research (4819) 4819
survival rate (4788) 4788
care and treatment (4652) 4652
medicine & public health (4599) 4599
follow-up studies (4534) 4534
cell line, tumor (4439) 4439
liver neoplasms - secondary (4317) 4317
adenocarcinoma - diagnosis (4264) 4264
mice (4247) 4247
adenocarcinoma - genetics (4226) 4226
adenocarcinoma - mortality (4183) 4183
gastroenterology & hepatology (3905) 3905
antineoplastic combined chemotherapy protocols - therapeutic use (3899) 3899
lung cancer (3866) 3866
stomach neoplasms - pathology (3827) 3827
pancreatic cancer (3765) 3765
diagnosis (3580) 3580
apoptosis (3575) 3575
health aspects (3490) 3490
prostatic neoplasms - pathology (3296) 3296
adenocarcinoma - therapy (3283) 3283
colorectal cancer (3254) 3254
diagnosis, differential (3235) 3235
pancreatic neoplasms - pathology (3197) 3197
tomography, x-ray computed (3025) 3025
proteins (3021) 3021
risk factors (2993) 2993
lung neoplasms - secondary (2983) 2983
neoplasm invasiveness (2982) 2982
gene expression (2958) 2958
development and progression (2699) 2699
genetic aspects (2682) 2682
combined modality therapy (2667) 2667
metastases (2636) 2636
adenocarcinoma - diagnostic imaging (2556) 2556
colorectal neoplasms - pathology (2553) 2553
adenocarcinoma - complications (2504) 2504
therapy (2489) 2489
disease-free survival (2479) 2479
survival analysis (2470) 2470
cell biology (2462) 2462
mutation (2421) 2421
neoplasm metastasis (2375) 2375
time factors (2366) 2366
prostate cancer (2363) 2363
radiotherapy (2358) 2358
gene expression regulation, neoplastic (2339) 2339
biopsy (2327) 2327
patients (2324) 2324
medical prognosis (2220) 2220
lung neoplasms - genetics (2217) 2217
colonic neoplasms - pathology (2195) 2195
lung neoplasms - drug therapy (2184) 2184
cancer therapies (2129) 2129
stomach cancer (2117) 2117
bone neoplasms - secondary (2102) 2102
breast-cancer (2084) 2084
biomarkers, tumor - metabolism (2071) 2071
cells (2064) 2064
medicine (2036) 2036
disease progression (2012) 2012
article (2001) 2001
respiratory system (1974) 1974
cell proliferation (1960) 1960
radiology, nuclear medicine & medical imaging (1951) 1951
prospective studies (1932) 1932
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (50571) 50571
Japanese (1454) 1454
French (917) 917
Spanish (634) 634
German (566) 566
Chinese (314) 314
Italian (229) 229
Russian (175) 175
Polish (117) 117
Portuguese (38) 38
Danish (37) 37
Korean (37) 37
Hungarian (36) 36
Dutch (35) 35
Czech (30) 30
Romanian (19) 19
Bulgarian (16) 16
Serbian (16) 16
Turkish (13) 13
Croatian (12) 12
Hebrew (9) 9
Norwegian (8) 8
Slovak (5) 5
Swedish (4) 4
Ukrainian (4) 4
Finnish (3) 3
Icelandic (2) 2
Greek (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 11/2006, Volume 12, Issue 21, pp. 6494 - 6501
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 101 - 108
Purpose To assess the survival benefit of early vs late salvage hormonal therapy (HT), we performed a secondary analysis on patients who developed recurrence... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | ANDROGEN DEPRIVATION | RELAPSE | ONCOLOGY | DEFINITIVE RADIOTHERAPY | RANDOMIZED-TRIAL | ABLATION | RECURRENCE | SUPPRESSION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ANTIGEN | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Prostatic Neoplasms - blood | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Salvage Therapy - mortality | Prostatic Neoplasms - pathology | Drug Administration Schedule | Adenocarcinoma - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Analysis of Variance | Neoadjuvant Therapy - methods | Survival Analysis | Aged | Salvage Therapy - methods | Adenocarcinoma - mortality | Medical research | Cancer patients | Care and treatment | Nuclear radiation | Patient outcomes | Adjuvant treatment | Medicine, Experimental | Radiotherapy | Prostate cancer | Cancer | Index Medicus | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | HEALTH HAZARDS | FAILURES | METASTASES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIOTHERAPY | HORMONES
Journal Article
The Journal of Pathology, ISSN 0022-3417, 02/2013, Volume 229, Issue 3, pp. 422 - 429
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT) for metastases limited in number and extent.... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | Index Medicus | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
MODERN PATHOLOGY, ISSN 0893-3952, 01/2018, Volume 31, Issue S1, pp. S80 - S95
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 2014, Volume 170, Issue 4, pp. 575 - 582
Journal Article
International Journal of Cancer, ISSN 0020-7136, 06/2019, Volume 144, Issue 11, pp. 2887 - 2896
Gefitinib, erlotinib and afatinib are approved for first‐line treatment of advanced non‐small cell lung cancer (NSCLC) bearing an activating epidermal growth... 
EGFR mutation | EGFR TKI | T790M | NSCLC | uncommon EGFR mutation | SURVIVAL | BIBW 2992 | PROGNOSTIC-FACTORS | SOLID TUMORS | ADENOCARCINOMA | OPEN-LABEL | IRREVERSIBLE EGFR | ONCOLOGY | RESISTANCE | TYROSINE KINASE INHIBITOR | PHASE-I | Lung Neoplasms - drug therapy | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Afatinib - pharmacology | Male | Liver Neoplasms - mortality | Carcinoma, Non-Small-Cell Lung - secondary | Time Factors | Female | Retrospective Studies | Liver Neoplasms - secondary | Afatinib - therapeutic use | Lung Neoplasms - genetics | Gefitinib - pharmacology | Liver Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Liver Neoplasms - drug therapy | Gefitinib - therapeutic use | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Drug Resistance, Neoplasm - genetics | Protein Kinase Inhibitors - therapeutic use | Erlotinib Hydrochloride - pharmacology | Progression-Free Survival | Taiwan - epidemiology | Sex Factors | Aged | Erlotinib Hydrochloride - therapeutic use | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Drug Resistance, Neoplasm - drug effects | Tyrosine | Yuan (China) | Care and treatment | Patient outcomes | Liver | Lung cancer, Small cell | Metastasis | Lung cancer, Non-small cell | Antineoplastic agents | Antimitotic agents | Liver cancer | Epidermal growth factor | Genetic aspects | Epidermal growth factor receptors | Lung cancer | Gene deletion | Multivariate analysis | Kinases | Patients | Survival | Clinical outcomes | Metastases | Confidence intervals | Clonal deletion | Deletion | Gefitinib | Health risk assessment | Growth factors | Protein-tyrosine kinase | Cancer | Index Medicus
Journal Article
Medicine (United States), ISSN 0025-7974, 07/2016, Volume 95, Issue 30, pp. e4385 - e4385
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 5/2016, Volume 23, Issue 5, pp. 1660 - 1665
Journal Article